Page 13 - Co Diagnostics News Today

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19 Impact & Forecasting/Analysis,...

Co-Diagnostics turns 1Q net profit of nearly $8M on strong sales of its Logix Smart COVID-19 Test Fueled by $20 million in revenue, net income was $7.9 million as compared to a net loss of $1.1 million in the prior-year quarter Looking to the second quarter, Co-Diagnostics gave revenue guidance in the range of $20 million to $22 million Co-Diagnostics Inc (NASDAQ:CODX) reported that it earned a first-quarter net profit -- versus a loss last year -- on strong sales of its Logix Sma...

Share this article SALT LAKE CITY, April 29, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be accompanying Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Lab ("CRL") in a webinar titled "A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19" on Thursday, April 29 at 2:00 PM EDT....

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

Co-Diagnostics says its CoSara joint venture in India garnering media attention as it combats coronavirus surge In particular, the Indian media have noted the extraordinary efforts of a CoSara team of six women who have increased capacity from roughly 8,000 coronavirus PCR tests per day a year ago to around 40,000 per day now In April 2020, CoSara, a joint venture with Synbiotics, became the first company headquartered in India to get a license to manufacture coronavirus test kits...

-- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test Kit was used by Australian researchers to demonstrate rapidly deployable mobile molecular diagnostics support for remote locations, with the peer-reviewed results published in the Journal of Medical Microbiology. The study was performed using readily available open-source equipment and materia...

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

Share this article SALT LAKE CITY, March 8, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (NASDAQ-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Company CEO Dwight Egan will present at the 2021 H.C. Wainwright & Co. Global Life Sciences Conference, being held virtually on March 9-10. Participants can register for the conference here. An archived version of the presentation can be ...